Neil Daly

Neil Daly, Founder and CEO of Skin Analytics, discusses the revolutionary role of AI in skin cancer diagnosis. He shares insights on the development of their medical device, DERM, which has gained regulatory approval in the UK. The conversation highlights how AI technology can enhance early diagnosis and improve patient outcomes, while emphasizing the importance of human oversight and patient trust. Daly also navigates the challenges of compliance and funding within the healthcare landscape, painting an optimistic picture for the future of AI in medicine.